The Venture Codex Logo

The Venture Codex

Canon

One Canon Park, Melville, NY, 11747, United States

Overview

Canon Europe is the European arm of Canon, a manufacturer of business and consumer imaging products worldwide. It distributes imaging products, including printers, scanners, binoculars, camcorders, photocopiers, steppers, computer printers, and medical equipment as well as a range of digital compact and SLR cameras. It offers print and document solutions for small and medium businesses, large corporations, and governments. The company’s portfolio of products includes multifunctional printers, black and white and color office printers, large format printers, scanners, black and white and color production printers, handy terminals and microfilm scanners, and software to support these products.

Total investments
2
Lead investments
0
Investments · 12mo
1
Active investors
0

Sector focus

  • Consumer Electronics
  • Electronics
  • Hardware
  • Manufacturing
Visit website

Investment portfolio

  • Rapidus

    Participated · Equity · Feb 2026

    Rapidus was founded in August 2022 and is led by CEO Atsuyoshi Koike. The company is developing advanced logic chip manufacturing at its IIM-1 facility in Chitose, Hokkaido, with plans to begin 2nm mass production by fiscal 2027. Rapidus works with IBM on process development and with IMEC in Belgium on broader R&D, and NEDO is involved in design projects alongside Fujitsu and IBM Japan. It was initially backed by eight major Japanese companies — Toyota, Sony, NTT, NEC, SoftBank, Denso, Kioxia, and MUFG — and early confirmed customers include Fujitsu and Tenstorrent. The government has become a major backer through sizeable R&D support and a February 2026 investment that left it with 11.5% of voting rights and a golden share veto. Rapidus is positioning itself as an alternative foundry offering small-volume, quick-turnaround services, but faces challenges securing steady customer orders and improving yields given competitors like TSMC and Samsung began 2nm volume production in 2025.

  • SuperSonic Imagine

    Participated · Series C · Nov 2010

    SuperSonic Imagine develops the Aixplorer® MultiWave™ Ultrasound System, an ultrasound imaging platform cleared by the FDA and bearing CE mark approval. The company intends to use new capital to accelerate development of its technology and finance worldwide commercialization of Aixplorer. After an initial focus on breast imaging, SuperSonic plans to expand clinical applications to liver, thyroid, abdominal, musculoskeletal, gynecological and prostate imaging, and to enable future therapeutic capabilities. The company sells directly in France, Germany, the USA and the UK and operates through a worldwide distribution network, including Hologic for the U.S. breast care market and Canon in Japan. Founded in 2005, SuperSonic also maintains offices in Seattle, London and Munich.

Team

No current team members are available.